Microencapsulated nerve growth factor-expressing NIH3T3 cells-incorporated tissue engineering skin: A preliminary study

Singapore Medical Journal

Volumn 47, Issue 6, 2006, Pages 504-511

  Hu, Z H ^a   Chen, S Z ^a   Jin, Y ^b   Xiong, Y ^c   Wang, W ^c   Ma, X J ^c   Song, M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Dalian Physical and Chemical Research Institute of Academia Sinica   (China)

Author keywords

Dermis; Gene transfection; Microencapsulation; Nerve growth factor; Tissue engineering

Indexed keywords

ALGINIC ACID; COLLAGEN; HYDROXYPROLINE; MICROSPHERE; NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MICROENCAPSULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; TISSUE ENGINEERING;

ALGINATES; ANIMALS; CELL NUCLEUS; DRUG COMPOUNDING; FEASIBILITY STUDIES; FIBROBLASTS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MICE; NERVE GROWTH FACTOR; NIH 3T3 CELLS; POLYLYSINE; RECEPTORS, NERVE GROWTH FACTOR; REGENERATION; SKIN PHYSIOLOGY; TISSUE ENGINEERING; TRANSFECTION;

EID: 33745151054     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Eming SA, Snow RG, Yarmush ML, et al. Targeted expression of insulin-like growth factor to human keratinocytes: modification of the autocrine control of keratinocyte proliferation. J Invest Dermatol 1996; 107:113-20.
2. Eming SA, Medalie DA, Tompkins RG, et al. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 1998; 9:529-39.
3. Supp DM, Supp AP, Bell SM, et al. Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. J Invest Dermatol 2000; 114:5-13.
4. Eming SA, Yarmush ML, Krueger GG, et al. Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor. Am J Pathol 1999; 154:281-9.
5. Hamoen KE, Morgan JR. Transient hyperproliferation of a transgenic human epidermis expressing hepatocyte growth factor. Cell Transplant 2002; 11:385-95.
6. Andree C. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci 1994; 91:12188-92.
7. Clark RAF. Wound repair: overview and general considerations. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1996:3-50.
8. Martin, P. Wound healing-aiming for perfect skin regeneration. Science 1997; 276:75-81.
9. Matsuda H, Kannan Y, Ushio H, Kiso Y, Kanemoto T et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991; 174: 7-14.
10. Young M, J. Ofer MH, Blanchard H, et al. Secretion of a nerve growth factor by primary chick fibroblast cultures. Science 1974; 187:361-2.
11. Tron VA, Coughlin DE, Jang J, et al. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990; 85:1085-9.
12. Leon A, Buriani R, dal Toso M, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci 1994; 91:3739-43.
13. Ehrhard PB, Erb P, Graumann U, et al. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci 1993; 90:10984-8.
14. Levi-Montalcini R, Angeletti PU. Essential role of the nerve growth factor on the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol 1963; 7:653-9.
15. Gee AP, Boyle L, Munger KL, et al. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci 1983; 80:7215-8.
16. Matsuda H, Koyama H, Sato H, et al. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 1998; 187:297-306.
17. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islets transplantation. Lancet 1994; 343:950-1.
18. Ross CJ, Ralph M, Chang PL. Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules. Hum Gene Ther 1999; 10:49-59.
19. Stockley TL, Robinson KE, Delaney K, et al. Delivery of recombinant product from subcutaneous implants of encapsulated recombinant cells in canines. J Lab Clin Med 2000; 135:484-92.
20. Machluf M, Orsola A, Atala A. Controlled release of therapeutic agents: slow delivery and cell encapsulation. World J Urol 2000; 18:80-3.
21. Joki T, Machluf M, Atala A, et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001; 19:35-9.
22. Sun Am, Fan MY, Lum ZP, et al. Bioartificial pancreas: reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Artif Organs 1989; 19:567-73.
23. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6:331-43.
24. Lange M, Malyusz M. Improved determination of small amounts of free hydroxyproline in biological fluids. Clin Chem 1994; 40:1735-8.
25. Nithya M, Suguna L, Rose C. The effect of nerve growth factor on the early responses during the process of wound healing. Biochim Biophys Acta 2003; 1620:25-31.
26. Liu Y, Jin Y, Wang X, et al. [Construction of a tissue engineering skin containing capillary-like network.] Chinese J Repair Reconstr Surg 2004; 18:502-4. Chinese.
27. Knighton DR, Hunt TK, Thakral KK, et al. Role of platelets and fibrin in the healing sequence: an in vitro study of angiogenesis and collagen synthesis. Ann Surg 1982; 196:379-88.
28. Dominguez ET, Castro-Munozledo F, Kuri-Harcuch. W. Growth factors and extracellular matrix proteins during wound healing promoted with frozen cultured sheets of human epidermal keratinocytes. Cell Tissue Res 2002; 307:79-89.
29. Erdag G, Medalie DA, Rakhorst H, Krueger GG, Morgan JR. FGF-7 expression enhances the performance of bioengineered skin. Mol Ther 2004; 10:76-85.
30. R. Rudolph. Location of the force of wound contraction. Surg Gynecol Obstet 1979; 4:547-51.
31. Sunilkumar SP, Sivakumar HG. Evaluation of topical formulations of aqueous extract of Centella asiatica on open wounds in rats. Indian J Exp Biol 1998; 36:569-72.
32. Chang TM. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnol Annu Rev 1995; 1:267-95.
33. Chang TM. Pharmaceutical and therapeutic applications of artificial cells including microencapsulation. Eur J Pharm Biopharm 1998; 45:3-8.
34. Dunphy JE, Udupa KN. Chemical and histochemical sequences in the normal healing of wounds. N Engl J Med 1955; 253:847-51.
35. Matsuda H, Switzer J, Coughlin J, et al. Human basophilic cell differentiation promoted by 2.5S nerve growth factor. Int Arch Allergy Immunol 1988; 86:453-7.